Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone for cerebral vasospasm after subarachnoid hemorrhage
IRCT20141209020258N82Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of milrinone in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Determine vasospasm of the cerebrovascular. Started Oct 2017; status: completed.
02
Drugs
milrinone
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on IRCT20141209020258N82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N82.